Companies
PTC Therapeutics completes ST-920 Fabry gene therapy buy from Sangamo
Close of the bankruptcy-auction deal follows August terms of $111 million upfront and up to $100 million in regulatory milestones; BLA filing targeted for Q4 2026.
Search stocks, ETFs and companies
Verified identity
Start with the filing record
The identity and ticker come from the SEC’s official company ticker mapping. Market and editorial coverage are not inferred from that record.
- Ticker
- PTCT
- CIK
- 0001070081
- Exchange
- Nasdaq
- Universe updated
- 2026-08-22
Market price
Market price
Latest quoteOpens Google
TickerGrove coverage
Latest on PTC THERAPEUTICS, INC.
Research foundation
Read the filing with the right frame
Company analysis
Revenue, EPS and guidance answer different earnings questions
Revenue is the top-line amount recognized from a company’s activities under its accounting policy.
Company analysis
The three financial statements describe one business from different angles
The income statement records revenue and expenses over a period.
Investing basics
Stocks, ETFs and indexes are different objects
A stock is an ownership interest in one company.